Israeli scientists are aiming to produce the world’s first preventative drug designed to stop tumors causing secondary cancer, and say the active ingredient has shown more than 90 percent effectiveness in mice.
The Bar Ilan University research team produced a peptide — a chain of amino acids — made to stop cancer cells from entering the blood and therefore halting them from moving around the body.
They have published peer-reviewed research showing that it successfully prevented metastasis in mice, meaning it prevented the spread of diseased cells that can cause secondary cancer.
Comments are closed.